MarketPulse
R

$RMD

2 articles found
2 positive
0 negative
0 neutral
The Motley FoolThe Motley Fool··Selena Maranjian

ResMed Eyes Growth Despite Healthcare Headwinds With Valuation Upside

ResMed trades at a 25% valuation discount despite 11% revenue growth and expanding digital health operations in 140+ countries, though Medicare reimbursement risks persist.
RMDstock valuationgrowth stocks
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Anti-Snoring Device Market Poised to Double by 2033 Amid Health Awareness Surge

Global anti-snoring devices market projected to nearly double to $3.36 billion by 2033, driven by obesity, health awareness, and technological advances.
GSKRMDPHGe-commercemarket growth